Drugs during pregnancy and lactation : treatment options and risk assessment, edited by Christof Schaefer, Paul Peters, and Richard K. Miller

Resource Information

The instance Drugs during pregnancy and lactation : treatment options and risk assessment, edited by Christof Schaefer, Paul Peters, and Richard K. Miller represents a material embodiment of a distinct intellectual or artistic creation found in Missouri University of Science & Technology Library. This resource is a combination of several types including: Instance, Electronic.

Image

http://images.btol.com/ContentCafe/Jacket.aspx?UserID=ebsco-test&Password=ebsco-test&Return=T&Value=9780124079014&Type=L

Label

Drugs during pregnancy and lactation : treatment options and risk assessment, edited by Christof Schaefer, Paul Peters, and Richard K. Miller

Title remainder

treatment options and risk assessment

Statement of responsibility

edited by Christof Schaefer, Paul Peters, and Richard K. Miller

Instantiates

• Drugs during pregnancy and lactation : treatment options and risk assessment

Publication

• London, UK, Elsevier/Academic Press, 2015

Copyright

• ©2015

Note

• Previous edition: 2007
• Translation of: Arzneimittel in Schwangerschaft und Stillzeit / Christof Schaefer ... (Hrsg.). Mit Beitr. von Stephanie Padberg ... 8., vollst. überarb. Aufl. 2012

Bibliography note

Includes bibliographical references and index

Carrier category

online resource

Carrier category code

• cr

Carrier MARC source

rdacarrier

Content category

text

Content type code

• txt

Content type MARC source

rdacontent

Contents

• Cover; Drugs During Pregnancy and Lactation; Copyright; Contents; List of Contributors; Preface; Disclaimer; 1 -- General commentary on drug therapy and drug risks in pregnancy; 1.1 Introduction; 1.2 Development and health; 1.3 Reproductive stages; 1.4 Reproductive and developmental toxicology; 1.5 Basic principles of drug-induced reproductive and developmental toxicology; 1.6 Effects and manifestations; 1.7 Pharmacokinetics of drugs in pregnancy; 1.8 Mechanisms of developmental toxic agents; 1.9 Causes of developmental disorders; 1.10 Embryo/fetotoxic risk assessment and plausibility
• 1.11 Classification of drugs used in pregnancy1.12 Paternal use of medicinal products; 1.13 Communicating the risk of drug use in pregnancy; 1.14 Risk communication prior to pharmacotherapeutic choice; 1.15 Risk communication regarding the safety of drugs already used in pregnancy; 1.16 Teratology information centers; References; 2 -- Specific drug therapiesduring pregnancy; 2.1 -- Analgesics, non-steroidal anti-inflammatory drugs (NSAIDs), muscle relaxants, and antigout medications; 2.1.1 Paracetamol (acetaminophen); 2.1.2 Acetylsalicylic acid; 2.1.3 Pyrazolone compounds and phenylbutazone
• 2.4.9 Other antiemeticsSummary; References; 2.5 -- Gastro-intestinal medications, hypolipidemic agents and spasmolytics; 2.5.1 Antacids; 2.5.2 Sucralfate and pirenzepine; 2.5.3 H2 receptor antagonists; 2.5.4 Proton pump inhibitors; 2.5.5 Bismuth salts; 2.5.6 Helicobacter pylori therapy; 2.5.7 Digestives and carminatives; 2.5.8 Atropine and other anticholinergic spasmolytics; 2.5.9 Cholinergics; 2.5.10 Constipation during pregnancy; 2.5.11 Antidiarrheal agents; 2.5.12 Medications for inflammatory bowel disease; 2.5.13 Chenodeoxycholic acid and ursodeoxycholic acid; 2.5.14 Lipid lowering agents

Control code

892869035

Edition

Third edition.

Extent

1 online resource

Form of item

online

Isbn

9780124079014

Media category

computer

Media MARC source

rdamedia

Media type code

• c

Other physical details

illustrations

http://library.link/vocab/ext/overdrive/overdriveId

425b2d77-08ae-4574-b033-1bdecf099469

Record ID

.b107838096

Specific material designation

remote

System control number

(OCoLC)892869035